Scientific evidence and financial obligations to ensure access to biosimilars for cancer treatment

Howard Bauchner; Phil B. Fontanarosa; Robert M. Golub

doi:10.1001/jama.2016.18743

Scientific evidence and financial obligations to ensure access to biosimilars for cancer treatment

Howard Bauchner^*, Phil B. Fontanarosa, Robert M. Golub

^*Corresponding author for this work

Medicine, General Medicine Division

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	33-34
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	317
Issue number	1
DOIs	https://doi.org/10.1001/jama.2016.18743
State	Published - Jan 3 2017

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jama.2016.18743

Cite this

@article{7fa18bd8c2df4ec680386f00772572c8,

title = "Scientific evidence and financial obligations to ensure access to biosimilars for cancer treatment",

author = "Howard Bauchner and Fontanarosa, {Phil B.} and Golub, {Robert M.}",

year = "2017",

month = jan,

day = "3",

doi = "10.1001/jama.2016.18743",

language = "English (US)",

volume = "317",

pages = "33--34",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Scientific evidence and financial obligations to ensure access to biosimilars for cancer treatment

AU - Bauchner, Howard

AU - Fontanarosa, Phil B.

AU - Golub, Robert M.

PY - 2017/1/3

Y1 - 2017/1/3

UR - http://www.scopus.com/inward/record.url?scp=85008386006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008386006&partnerID=8YFLogxK

U2 - 10.1001/jama.2016.18743

DO - 10.1001/jama.2016.18743

M3 - Editorial

C2 - 27918795

AN - SCOPUS:85008386006

SN - 0098-7484

VL - 317

SP - 33

EP - 34

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 1

ER -

Scientific evidence and financial obligations to ensure access to biosimilars for cancer treatment

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this